PE20001558A1 - Composiciones analgesicas que comprenden compuestos antiepilepticos - Google Patents

Composiciones analgesicas que comprenden compuestos antiepilepticos

Info

Publication number
PE20001558A1
PE20001558A1 PE2000000204A PE0002042000A PE20001558A1 PE 20001558 A1 PE20001558 A1 PE 20001558A1 PE 2000000204 A PE2000000204 A PE 2000000204A PE 0002042000 A PE0002042000 A PE 0002042000A PE 20001558 A1 PE20001558 A1 PE 20001558A1
Authority
PE
Peru
Prior art keywords
methyl
compositions including
analgesic compositions
antiepileptic compounds
alkyl
Prior art date
Application number
PE2000000204A
Other languages
English (en)
Inventor
Trevor Mundel
Mark Richard Hurtt
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20001558A1 publication Critical patent/PE20001558A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMBINACION DE i)UN COMPUESTO ANTIEPILEPTICO DE FORMULA I, DONDE: R1 ES H, ALQUILO, n ES 4-6, EL ANILLO CICLICO ES OPCIONALMENTE SUSTITUIDO; (H2N)(R13)-CH-C(R12)(R11)-CH2COOH, R11 ES ALQUILO C1-C6, FENILO, CICLOALQUILO C3-C6, R12 ES H, METILO; R13 ES H, METILO, CARBOXILO, O GABAPENTINA, PREGABALINA, ii)AL MENOS UNO O COMBINACIONES DE a)UN ANTAGONISTA DEL RECEPTOR N-METIL-D-ASPARTATO (NMDA); b)ANALGESICOS NO ESTEROIDEOS TAL COMO NAPROXENO, c)UN ANALGESICO NARCOTICO TAL COMO MORFINA. LA COMBINACION PUEDE SER UTIL PARA TRATAR EL DOLOR
PE2000000204A 1999-03-10 2000-03-08 Composiciones analgesicas que comprenden compuestos antiepilepticos PE20001558A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12373999P 1999-03-10 1999-03-10

Publications (1)

Publication Number Publication Date
PE20001558A1 true PE20001558A1 (es) 2001-01-28

Family

ID=22410582

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000204A PE20001558A1 (es) 1999-03-10 2000-03-08 Composiciones analgesicas que comprenden compuestos antiepilepticos

Country Status (11)

Country Link
US (1) US6451857B1 (es)
EP (1) EP1161263A1 (es)
JP (1) JP2002538221A (es)
AR (1) AR022723A1 (es)
AU (1) AU3216600A (es)
BR (1) BR0008847A (es)
CA (1) CA2359485A1 (es)
CO (1) CO5150189A1 (es)
PE (1) PE20001558A1 (es)
UY (1) UY26052A1 (es)
WO (1) WO2000053225A1 (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0934061T6 (en) 1996-07-24 2015-01-26 Warner Lambert Co Isobutylgaba and its derivatives for the treatment of pain
EP1011658B1 (en) 1997-09-08 2005-12-07 Warner-Lambert Company Llc Analgesic compositions comprising anti-epileptic compounds and methods of using same
MXPA02000170A (es) * 1999-07-02 2002-07-02 Warner Lambert Co Una combinacion sinergica: gabapentin y pregablin.
ZA200108038B (en) * 2000-10-02 2003-04-01 Pfizer Prod Inc Prophylactic use of n-methyl-d-asparrate (NMDA) antagonists.
CA2449987C (en) 2001-06-07 2015-11-03 Christine N. Sang Treatment of central neuropathic pain
SI1423168T1 (sl) * 2001-09-03 2006-06-30 Newron Pharm Spa Farmacevtski sestavek, ki vsebuje gabapentin ali njegov analog in alfa-aminoamid, in njegova analgetska uporaba
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US6730667B2 (en) * 2001-11-26 2004-05-04 William R. Deagle Iontophoresis disc pain blocker
WO2003061656A1 (en) * 2002-01-16 2003-07-31 Endo Pharmaceuticals Inc. Pharmaceutical composition and method for treating disorders of the central nervous system
AU2003207219A1 (en) 2002-02-05 2003-09-02 Ajinomoto Co., Inc. Medicinal compositions containing gabapentin or pregabalin and n-type calcium channel antagonist
CA2476438A1 (en) * 2002-02-22 2003-08-28 Warner-Lambert Company Llc Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
FR2862875B1 (fr) * 2003-12-02 2006-04-07 Mathey Acoustique Service Preparation pharmaceutique pour le traitement des acouphenes
WO2005102390A2 (en) * 2004-04-22 2005-11-03 Pfizer Japan, Inc. Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
SI1963280T1 (sl) 2005-12-22 2016-02-29 Newron Pharmaceuticals S.P.A. 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
MX2009002002A (es) * 2006-08-23 2009-07-22 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potasio.
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
MX2009005652A (es) * 2006-11-28 2009-08-07 Valeant Pharmaceuticals Int Analogos 1,4 diamino biciclicos de retigabina como moduladores de canales de potasio.
EA017171B1 (ru) * 2006-12-22 2012-10-30 Рекордати Айерленд Лимитед КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
EP2116539A1 (en) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
EP2116618A1 (en) 2008-05-09 2009-11-11 Agency for Science, Technology And Research Diagnosis and treatment of Kawasaki disease
US20100190752A1 (en) 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
CN102223791A (zh) 2008-09-27 2011-10-19 塔阿克斯有限公司 用于神经病变治疗的局部用制剂
AU2009302241B2 (en) 2008-10-08 2015-10-29 Xgene Pharmaceutical Inc. GABA conjugates and methods of use thereof
MX2016007286A (es) * 2013-12-17 2016-08-04 Esteve Labor Dr Combinaciones de gabapentinoides y ligandos de receptores sigma.
AU2014364647A1 (en) 2013-12-17 2016-06-23 Laboratorios Del Dr. Esteve, S.A. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations
CA2951987C (en) 2014-06-16 2017-10-24 Farmaceuticos Rayere, S.A. Pharmaceutical composition that combines an anticonvulsant and a nicotinic acid derivative
MX2015016589A (es) 2015-12-02 2017-06-01 Samuel CHAIT AUERBACH Jaime Composicion oral veterinaria con gabapentina.
US10052296B2 (en) * 2016-04-07 2018-08-21 Nevakar Inc. Formulations for treating pain
WO2017200700A1 (en) * 2016-05-16 2017-11-23 PixarBio Corporation Methods for treating incisional pain
US11590094B2 (en) 2017-09-28 2023-02-28 Nevakar Injectables Inc. Fixed dose combination formulations for treating pain
US11547686B2 (en) 2017-10-03 2023-01-10 Nevakar Injectables Inc. Acetaminophen pregabalin combinations and methods of treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694010A (en) * 1985-08-16 1987-09-15 New York University Anticonvulsant compositions and method
JP2001500121A (ja) * 1996-08-23 2001-01-09 アルゴス ファーマシューティカル コーポレーション 神経障害性の痛みを治療する組成物を含む抗けいれん剤
WO1999008670A1 (en) 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
EP1011658B1 (en) 1997-09-08 2005-12-07 Warner-Lambert Company Llc Analgesic compositions comprising anti-epileptic compounds and methods of using same

Also Published As

Publication number Publication date
AR022723A1 (es) 2002-09-04
CO5150189A1 (es) 2002-04-29
EP1161263A1 (en) 2001-12-12
BR0008847A (pt) 2001-12-26
UY26052A1 (es) 2000-08-21
CA2359485A1 (en) 2000-09-14
US6451857B1 (en) 2002-09-17
WO2000053225A1 (en) 2000-09-14
JP2002538221A (ja) 2002-11-12
AU3216600A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
PE20001558A1 (es) Composiciones analgesicas que comprenden compuestos antiepilepticos
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
ATE440833T1 (de) Antithrombotische diamide
EA201001015A1 (ru) Карбамоиловые соединения в качестве ингибиторов dgat1 190
RU2008139315A (ru) Избирательные андрогенные рецепторные модуляторы
CY1108573T1 (el) Ανταγωνιστες νρυυ5
GB0428514D0 (en) Compounds
EA200500238A1 (ru) Новый способ синтеза ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
RS53503B1 (en) AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR
RS51943B (en) PIPERIDINSKI GPCR AGONIST
EA200600925A1 (ru) Производные триазола в качестве антагонистов вазопрессина
DOP2011000196A (es) Compuestos purina
ATE272633T1 (de) Aromatische amiden
CY1108738T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για την αγωγη του πονου
ES2184482T3 (es) Benzazoles, derivados del venzoxazol, el benzotiazol y el bencimidazol.
RS54485B1 (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
ES2185606T3 (es) Nuevo uso de una clase de compuestos peptidicos para tratamiento de la alodinia u otros tipos diferentes de dolor cronico o fantasma.
PA8852101A1 (es) Nucleótidos uracil ciclopropílicos
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
EA200200819A1 (ru) Кристаллическая форма ii линезолида
EA200801596A1 (ru) Новые 11-бета-гидроксиандроста-4-ен-3-оны
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
GB0701365D0 (en) Novel pharmaceutical compositions
TW200716597A (en) Novel piperidine-substituted indoles
EA200900732A1 (ru) Кристаллическая калиевая соль аналогов липоксина а

Legal Events

Date Code Title Description
FC Refusal